Strategic collaboration with LaunXP for the development of vebreltinib in combination with an EGFR inhibitor ("EGFRi”) to ...

As the Trump administration makes major cuts to federal health agencies, including the National Institutes of Health, cancer ...

I-Mab (NASDAQ: IMAB) is a U.S.-based, global biotech company, focused on the development of precision immuno-oncology agents for the treatment of cancer. I-Mab has established operations in the U.S.

Former Bachelorette lead, Katie Thurston, 34, went to her first chemotherapy class this week as she fights stage 4 cancer, ...

Learn about how different healthcare providers work together to help breast cancer patients weigh their treatment options.

Marla Anderson, MD, FACS, is a board-certified surgeon specializing in breast oncology and surgical treatment for breast ...

Teddi Mellencamp’s cancer has officially reached stage 4. The Real Housewives of Beverly Hills alum, 43, took to her ...

The new FX series Dying for Sex tells the true story of Molly Kochan, a woman who went on a journey to explore her sexuality ...

A growing number of physicians are starting to shift their thinking about multiple myeloma’s prognosis. For years, patients ...

In a study co-led by the University of Maryland School of Medicine (UMSOM), researchers have identified a "master regulator" ...

Despite declaring himself cancer-free in 2021, Kilmer’s health had reportedly never recovered from his treatment, which ...

Tourmaline Bio's Pacibekitug shows promise in IL-6 targeting for autoimmune diseases. Learn about its potential and ongoing trials. Read why TRML is a hold.